JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.
JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.